Search filters

List of works by Mara A Bonelli

Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation

scientific article published on 19 March 2016

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

scientific article published on 12 December 2012

Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines

scientific article published on February 2008

Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines

scientific article

Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling

scientific article published on 21 August 2013

Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer

scientific article published on January 2013

Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines

scientific article

Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines

Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification

scientific article (publication date: 2013)

Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones

scientific article

Synergistic activity of letrozole and sorafenib on breast cancer cells

scientific article

Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC